But a new report by a higher education advocacy group says that statistic offers an incomplete picture. While the completion ...

Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients ...